Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs

Photoactivatable Pt(IV) anticancer prodrugs with the structure of [Pt(IV)(N(1))(N(2))(L(1))(L(2))(A(1))(A(2))], where N(1) and N(2) are non-leaving nitrogen donor ligands, L(1) and L(2) are leaving ligands, and A(1) and A(2) are axial ligands, have attracted increasing attention due to their promisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jingjing, Ding, Weize, Zhu, Xingfan, Li, Bingbing, Zeng, Fangang, Wu, Kui, Wu, Xiaoqin, Wang, Fuyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218644/
https://www.ncbi.nlm.nih.gov/pubmed/35755267
http://dx.doi.org/10.3389/fchem.2022.876410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218644/
https://www.ncbi.nlm.nih.gov/pubmed/35755267
http://dx.doi.org/10.3389/fchem.2022.876410

Ejemplares similares